Genedrive collects £0.76m R&D tax credit

5th Jun 2026 12:12

(Sharecast News) - Genedrive said on Friday that it had received a research and development tax credit refund of about £0.76m from HMRC.

The AIM-traded point-of-care pharmacogenetic testing company said the refund related to the financial years ended 30 June 2024 and 30 June 2025.

At 1100 BST, shares in Genedrive were up 4% at 1.3p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

Top Risers

Share	Price	Change
Beowulf Mining PLC (BEM)	9.00	63.64%
Raspberry Pi (RPI)	1,051.00	27.63%
Forgent (FORG)	0.0185	26.67%
Image Scan Holdings (IGE)	2.20	25.71%
Accesso Technology Group (ACSO)	319.00	21.99%

Top Fallers

Share	Price	Change
Cleantech Lithium (CTL)	5.90	-25.32%
Oriole Resources (ORR)	0.355	-17.81%
Bradda Head Lithium (BHL)	2.85	-16.18%
Mercantile Ports & Logistics (MPL)	1.30	-16.13%
Adm Energy (ADME)	0.0225	-15.09%

Top By Volume

Share	Price	Volume
Premier African Minerals (PREM)	0.023	1,148,220,166
Ethernity Net (ENET)	0.0014	624,853,017
Quantum Helium (QHE)	0.02475	535,986,343
Alba Mineral Resources (ALBA)	0.015	458,461,414
Forgent (FORG)	0.0185	386,590,922

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.